Basic Sciences for the Conquest of COVID-19
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "SARS-CoV-2 and COVID-19".
Deadline for manuscript submissions: closed (30 September 2024) | Viewed by 36858
Special Issue Editors
Interests: HIV-1; restriction factors; SARS-CoV-2 variants
Special Issue Information
Dear Colleagues,
The COVID-19 pandemic—caused by SARS-CoV-2, which is phylogenetically derived from animal coronaviruses—is a once-in-a-century disaster. Since the emergence of this zoonotic virus, a growing number of scientists all over the world have been tackling this global crisis as a matter of urgency, attempting to conquer this killer virus that threatens billions of lives. Thus, the international power of science has led to a tremendous number of informative results in a short period of time.
This Special Issue of Viruses will cover 1) SARS-CoV-2 replication mechanisms through host–virus interactions, including cell entry, RNA replication, viral protein synthesis, and virus production; 2) infection-induced innate immunity, cell signaling, and cell damage; 3) the viral pathogenicity of different variant strains, represented by clinical outcomes and immune responses in humans; 4) SARS-CoV-2 infection in several different animal models; 5) therapeutic approaches, such as vaccines, antiviral drugs, passive immunization, and inflammation inhibitors, among others.
Original articles, comprehensive reviews, short communications, and new perspectives are welcome.
Dr. Kenzo Tokunaga
Dr. Jérôme Estaquier
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-CoV-2
- host–pathogen interactions
- virus replication
- immune response
- viral pathogenicity
- animal models
- therapeutic strategies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.